CAS 127984-74-1

10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide

Description:

The chemical substance known as "10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1-carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide" with CAS number 127984-74-1 is a complex organic compound characterized by its multi-functional groups and structural intricacies. It features a pentazacycloicosane backbone, which contributes to its unique three-dimensional conformation and potential biological activity. The presence of various functional groups, including amines, hydroxyls, and carbonyls, suggests that this compound may exhibit significant reactivity and solubility in polar solvents. Its structural components, such as the indole and naphthalene moieties, indicate potential interactions with biological targets, making it of interest in medicinal chemistry. The compound's extensive functionalization may also influence its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion. Overall, this substance represents a fascinating area of study for researchers exploring novel therapeutic agents.

Formula: C₅₄H₆₉N₁₁O₁₀S₂xC₂H₄O

InChI: InChI=1/C54H69N11O10S2.C2H4O2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55;1-2(3)4/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74);1H3,(H,3,4)

SMILES: CC(C)C1C(=NC(CSSCC(C(=NC(Cc2ccc(cc2)O)C(=NC(Cc2c[nH]c3ccccc23)C(=NC(CCCCN)C(=N1)O)O)O)O)N=C(C(Cc1ccc2ccccc2c1)N)O)C(=NC(C(C)O)C(=N)O)O)O.CC(=O)O

Synonyms:

• Lanreotide Acetate
• 10-(4-Aminobutyl)-19-[(2-Amino-3-Naphthalen-2-Yl-Propanoyl)Amino]-N-(1-Carbamoyl-2-Hydroxy-Propyl)-16-[(4-Hydroxyphenyl)Methyl]-13-(1H-Indol-3-Ylmethyl)-6,9,12,15,18-Pentaoxo-7-Propan-2-Yl-1,2-Dithia-5,8,11,14,17-Pentazacycloicosane-4-Carboxamide

Lanreotide acetate

CAS: 127984-74-1

Formula: C₅₄H₆₉N₁₁O₁₀S₂·xC₂H₄O₂

Purity: ≥ 98.0%

Color and Shape: White to off-white solid

Molecular weight: 1096.32 (free base)

Ref: 7W-GK2805

Lanreotide Acetate

CAS: 127984-74-1

Formula: C₅₄H₆₉N₁₁O₁₀S₂

Purity: 95%~99%

Color and Shape: White to Off-white Powder

Molecular weight: 1096.33

Ref: BP-BPPG043

Lanreotide Acetate

Controlled Product

CAS: 127984-74-1

Applications Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma.
References Kuehnen, P. et al.: Horm. Res. Paediat., 78, 106 (2012); Li, Z. et al.: J. Int. Med. Res., 40, 517 (2012);

Formula: C₅₄H₆₉N₁₁O₁₀S₂·C₂H₄O₂

Color and Shape: Neat

Molecular weight: 1156.38

Ref: TR-L174600

Lanreotide acetate

CAS: 127984-74-1

Lanreotide Acetate is a synthetic cyclic peptide with anti-cancer properties and is used for the treatment of carcinoid syndrome. It binds to somatostatin receptors and inhibits the release of hormones such as gastrin, secretin, vasoactive intestinal peptide, and pancreatic polypeptide. Lanreotide Acetate is used in the treatment of symptoms that are typical for carcinoid syndrome and can also be used in combination with goserelin acetate or triptorelin acetate for patients who do not respond to lanreotide alone. The drug has been shown to be well tolerated in clinical trials and does not show any significant toxicity.

Formula: C₅₄H₆₉N₁₁O₁₀S₂•(C₂H₄O₂)x

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 1,156.4 g/mol

Ref: 3D-CFA98474

Lanreotide acetate - Bio-X ™

Controlled Product

CAS: 127984-74-1

Lanreotide is a somatostatin analog that is used for the treatment of tumors and acromegaly. This drug inhibits the growth hormone in the brain and induces apoptosis. Lanreotide also has antiproliferative properties as it blocks production that leads to tumor growth.

Formula: C₅₆H₇₃N₁₁O₁₂S₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 1,156.4 g/mol

Ref: 3D-DVD11472